metaPreg - Elexacaftor, tezacaftor and ivacaftor (ETI) during pregnancy

Elexacaftor, tezacaftor and ivacaftor (ETI) updated on 05-04-2026

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Growth parameters and prematurity
1 non statistically significant endpoints reported in only one study
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Gestational diabetes	3.89 [1.19, 12.68]	-	1 study	27	24	not evaluable	ROB	7.23 [1.67; .]